Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1031 | 1031 | 1068 | 998 | 1327 | 1264 |
Fund Return | 3.13% | 3.14% | 6.75% | -0.05% | 5.82% | 2.37% |
Place in category | 988 | 1016 | 1048 | 1394 | 801 | 634 |
% in Category | 46 | 47 | 52 | 77 | 52 | 68 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife Global Asia REIT AA G | 285.11M | -4.99 | -4.98 | - | ||
Manulife Global Fund Global Equity | 257.4M | 6.62 | 5.49 | 6.43 | ||
Manulife Glbl Fund Asian Eq Fund I | 111.1M | 6.29 | -6.89 | 3.66 | ||
Manulife Glbl Fund Asian Eq Fund AA | 111.1M | 6.01 | -7.62 | 2.92 | ||
Manulife Glbl Fund Asian Eq I3 USD | 111.1M | -17.66 | 4.06 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MFSM European Value Fund I1 USD | 2.73B | -1.14 | 2.48 | 6.03 | ||
MFSM European Value Fund N1 USD | 2.73B | -1.35 | 0.97 | 4.46 | ||
MFSM European Value Fund W1 USD | 2.73B | -1.16 | 2.23 | 5.78 | ||
MFSM European Value Fund A1 USD | 2.73B | -1.29 | 1.47 | 4.99 | ||
Europe Equity Plus Fund A perf acc | 1.96B | 9.06 | 6.71 | 4.68 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ASML Holding | NL0010273215 | 5.52 | 859.30 | +0.66% | |
Novo Nordisk B | DK0062498333 | 5.38 | 915.8 | -1.23% | |
SAP | DE0007164600 | 3.42 | 179.240 | -0.42% | |
AstraZeneca | GB0009895292 | 3.20 | 12,362.0 | -0.02% | |
Louis Vuitton | FR0000121014 | 3.11 | 759.20 | -1.16% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review